National Academy of Sciences | 150 Year Anniversary

Questions? Call 800-624-6242

| Items in cart [0]

The National Academies Press

HARDBACK
price:$81.25
add to cart

Rights & Permissions

topleft topright

A Review of the Dose Reconstruction Program of the Defense Threat Reduction Agency (2003)
Board on Radiation Effects Research (BRER)

Citation Manager

. "Appendix D: Responses to Committee's Questions." A Review of the Dose Reconstruction Program of the Defense Threat Reduction Agency. Washington, DC: The National Academies Press, 2003.

Please select a format:

BibTeX EndNote RefMan


Page
306
bottomleft bottomright

The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy.


Defense Threat Reduction Agency

8725 John J Kingman Road MS 6201 Ft Belvoir, VA 22060-6201

SEP 2 8 2001

John Till, Ph.D.

Chairman,

Committee to Review DTRA Dose Reconstruction Program

National Academy of Sciences

Board on Radiation Effects Research

2101 Constitution Avenue, NW Washington, DC 20418

Dear Dr. Till:

This is in reply to your letter dated September 6, 2001. The following responses are provided with respect to the questions posed by the National Research Council Committee to Review the Dose Reconstruction Program of the Defense Threat Reduction Agency and the Board on Radiation Effects Research. Per our conversation with NAS’ Dr. Al-Nabulsi on 7 September 2001, we indicated it would be appropriate for DTRA to respond to questions 5, 6, 8, 9, 10, 11, 12, 13, 14, and 16 and provide comments on the flow chart pertaining to DTRA responsibilities. We recommended questions 1 through 4 should be referred to Department of Veterans Affairs (VA), Office of the Undersecretary for Benefits and questions 7, 8, 10, and 15 to VA, Office of the Undersecretary for Health.

Question 5. When a claimant is referred to JAYCOR, is the dose of record then sent to VA and DTRA or only to DTRA?

Reply: When a dose is provided for a claim referred to JAYCOR, the dose information is given to DTRA for review and approval. DTRA then sends the dose information to both the VA and the claimant. In cases where the claimant’s address is not known, DTRA requests the VA to forward a copy to the claimant.

Question 6. Under what circumstances is the file referred to SAIC for a dose and in what circumstances is this not done?

Reply: Claimant files not referred to SAIC are under the following circumstances:

1997

non-participant cases (these cases are not verified participants);

1998

presumptive cases (these cases do not require dose information); and

Page
306